English Swedish
Published: 2010-02-24 12:00:00 CET
C-Rad AB
Company Announcement
Lund University confirms image quality of Gemini ED
C-RAD AB and its three wholly owned subsidiaries are all active in the field
of
radiation therapy. Scientists at Lund University confirm that the images
from
the flat panel imager Gemini ED have reached a quality that is comparable
or
better than the existing systems on the market. 

C-RAD Gemini system is
based on technology originally developed at CERN in
Switzerland. Since then,
the technology has been developed for use in medical
applications by Professor
Anders Brahme and his team at the Karolinska
Institutet in Stockholm. C-RAD
holds three patents, which ensures the
protection of the unique technology.

Within the framework of the cooperation with Skåne University Hospital
(SUS),
C-RAD Imaging AB carried out several series of tests at the SUS
radiotherapy
department in Lund. Different generations of detectors and image
panels were
tested, ranging from a first simple prototype to the now finished
product
Gemini ED. Staff at Lund University and SUS has been able to follow
the
evolution of the product and also noted the gradual improvement of the
image
quality. A dedicated and innovative development work has now resulted in
a
competitive product, with benefits exceeding existing flat panel imagers
for
use in radiation therapy. 

Crister Ceberg, Associate Professor of
Medical Radiation Physics, Lund
University: 
"It's been exciting to follow
the development of the Gemini-detector. When I
saw the pictures of the first
version, where you could see a wrench placed in
the field, I felt there was a
long way to go. Many versions later , and after
several tests in Lund, the
images that are now being produced are much more
impressive, and you can see
that Gemini detector has reached an image quality
that is comparable or better
than existing systems on the market. " 



Erik Hedlund, CEO, C-RAD
AB:

”The cooperation with Crister Ceberg at Lund University has been crucial
in the
development of the Gemini detector. The tests, conducted during late
evenings
and weekends, have given the employees of C-RAD important information
during
the development, and knowledge of the requirements, clinicians are
putting
regarding the quality of the imaging systems.” 

For further
information: 

Erik Hedlund, CEO C-RAD AB, Telefon 018 - 66 69 31, E-post
erik.hedlund@c-rad.se
 


file2.pdf